Regardless of a slight decline in investments in digital well being startups in 2024 in contrast with the 12 months earlier than, traders stay optimistic concerning the panorama.
Synthetic intelligence has taken middle stage this 12 months, and traders will doubtless proceed to pour hundreds of thousands into startups promoting AI-powered healthcare instruments for years to come back.
That is very true for firms that may reveal their return on funding and align themselves with key metrics prospects use to measure success. Since 2023, traders have been focusing much less on pure development and extra on startups that may show themselves as priceless to suppliers and payers — and that pattern is anticipated to proceed.
Buyers additionally predict that startups specializing in value-based care and Medicare Benefit may additionally turn into a sought-after class within the digital well being area within the coming years, partially influenced by the incoming presidential administration.
What has this 12 months’s funding atmosphere seemed like?
All through the primary three quarters of this 12 months, the U.S. digital well being sector raised $8.2 billion throughout 379 offers.
That is barely down from 2023 — the primary three quarters of final 12 months ended with $8.6 billion raised, and the 12 months completed with a digital well being funding whole of $10.7 billion from 492 offers.
The {dollars} raised in 2023 marked the bottom annual funding quantity the digital well being sector had seen since 2019 — and that pattern will doubtless not be reversed this 12 months. The information thus far signifies that the sector is on monitor to complete 2024 with a good decrease funding whole — however that doesn’t essentially imply that the sector is struggling.
In reality, the digital well being funding area is transferring from irrational exuberance to reasoned funding primarily based on enterprise fundamentals.
The digital well being atmosphere continues to be normalizing after the pandemic-fueled funding frenzy from 2020 to 2022 — during which FOMO (concern of lacking out) was rampant amongst traders and valuations have been typically exaggerated, famous Prateesh Maheshwari, managing director at Maverick Ventures.
He identified that traders have continued to make seed and Sequence A offers this 12 months as a result of these early-stage investments are likely to keep away from near-term market dangers. However, he stated growth-stage funding “feels acutely completely different” than a pair years in the past.
“There have been so many traders — who have been historically public traders or development traders, who didn’t have a healthcare focus — who had stepped in throughout 2021, and people people have exited,” Maheshwari declared.
It is sensible that these traders would lose some curiosity in digital well being startups, he stated.
In spite of everything, they’re often targeted on development unit economics, with the expectation that any firm they put money into may find yourself buying and selling within the public market. However “the general public markets haven’t been tremendous useful to digital well being firms over the previous 12 months,” he famous. Inventory costs from firms corresponding to Teladoc, 23andMe and CVS Well being have all struggled this 12 months.
Nonetheless, the digital well being sector noticed indicators of life within the public markets this 12 months. Final 12 months noticed zero preliminary public choices, however two digital well being firms — Waystar and Tempus AI — have filed IPOs in 2024, and Nuvo went public by means of a particular objective acquisition firm merger.
Maheshwari thinks issues will proceed to enhance in 2025.
“General, it’s been a more durable 12 months for founders to boost — however I feel one of many fascinating observations is that every quarter, it felt prefer it obtained a bit bit higher for founders. For those who take that pattern line into 2025 — you’re taking the fairness markets in any respect time highs, you’re taking the quantity of capital sitting in several enterprise funds, and the potential for exits on the enterprise aspect with some current IPOs, I feel you can see the market actually open up once more,” he remarked.
AI is having one other scorching 12 months
Buyers have been ebullient about AI this 12 months — particularly AI because it pertains to administrative use circumstances, Maheshwari said.
He stated that each healthcare startup ought to have some component of AI, whether or not it’s a major providing or getting used to allow different elements of the enterprise.
“It looks like if you happen to’re not utilizing it, you’re prone to fall behind rivals. [AI] is one thing that we usually see included in each pitch — however having clear use circumstances is crucial,” Maheshwari declared.
Income cycle administration is one AI use case traders are inquisitive about, he famous.
For example, SmarterDx, an AI startup that gives scientific evaluate and high quality audits for medical claims, raised $50 million in Could, and Adonis, which additionally makes use of AI to make sure correct billing and well timed funds, snagged $31 million in June.
“[Revenue cycle management] is an area that type of looks like a consensus alternative. On each the plan and the supplier aspect, the submission of payments, danger adjustment and assessing claims are all issues that I feel seem to be considerably inevitable use circumstances for AI. And also you’re seeing lots of early adoption round these use circumstances,” Maheshwari defined.
Buyers have additionally demonstrated a selected curiosity in startups utilizing AI to simplify the scientific documentation course of, he added. For instance, scientific documentation AI startup Abridge closed a $150 million funding spherical in February, and Suki secured $70 million for its AI-powered voice assistant in October.
Buyers are pouring capital into AI-powered documentation startups as a result of these firms are proving their worth to their prospects, Maheshwari stated. Well being methods throughout the nation have been launching enterprise-wide deployments of those AI instruments this 12 months following profitable pilots, with the instruments typically shaving off hours of administrative duties every week for clinicians.
Maheshwari stated the success of administrative task-focused startups may trigger investments to choose up for startups utilizing AI for extra scientific use circumstances, corresponding to therapy optimization or diagnostic help.
In alignment with Maheshwari, Steve Kraus, a companion at Bessemer Enterprise Companions, additionally highlighted AI startups which might be going after administrative inefficiencies as the most well liked class inside digital well being.
A few his portfolio firms that match into this class are Plenful and Qventus. Plenful sells a software program platform that automates the guide duties that burden pharmacy employees, and Qventus presents expertise to automate surgical procedure scheduling.
There may be one other space the place AI may discover a good dwelling.
Rising pharmacy prices are a major downside for payers and employers, which is driving demand for automation options within the pharmacy operations area, Kraus famous. He additionally identified that with hospital margins underneath strain, instruments that enhance income seize in high-cost areas, like Qventus’ answer for filling open surgical procedure slots, are significantly interesting.
“{AI on the] administrative aspect has actually gotten unbelievable traction — these firms are rising actually quick, and gross sales cycles are pressed in comparison with conventional healthcare gross sales cycles,” Kraus declared. “Hospitals are signing up and paying for this software program that’s AI-powered in form of report numbers versus what I’ve seen earlier than in my 20 years in healthcare.”
Might funding in particular areas decide up underneath a brand new presidential administration?
Kraus predicted that 2025 might even see extra funding within the Medicare Benefit area.
He famous that Medicare Benefit has confronted challenges in recent times, together with public coverage scrutiny and well being methods dropping Medicare Benefit contracts. Nonetheless, he thinks the sector will rebound underneath the incoming administration of President-elect Donald Trump, which can doubtless be in favor of privatized healthcare.
Buyers could begin paying extra consideration to value-based care startups as effectively, Kraus stated. Worth-based care has acquired bipartisan assist throughout each presidential administration previously decade, he identified.
He additionally highlighted Robert F. Kennedy Jr.’s “Make America Wholesome Once more” imaginative and prescient — which emphasizes preventive care and whole-person therapy methods.
“‘Make America Wholesome Once more’ is type of about preventive, proactive care administration — how you can get forward of issues. Actually, that’s what worth primarily based care is attempting to do, proper? It’s attempting to deal with somebody in a holistic method — treating the entire course of somebody’s life, reasonably than simply an episode once they present as much as the dialysis middle or once they present as much as get their knee operated on,” Kraus remarked.
What do startups do to achieve success in 2025?
To achieve success in at this time’s funding panorama, digital well being startups want to grasp their prospects effectively, stated Chirag Shah, a companion at Outline Ventures.
“I feel extra vital than the precise use case goes to be ensuring people actually perceive how their consumers are literally evaluating them,” he remarked. “In 2025, individuals are in search of the way you ship near-term ROI and the way built-in you might be into their workflows for what their clinicians and different professionals are doing day-to-day.”
Moreover, digital well being startups must have a powerful cybersecurity plan, Shah added.
Guaranteeing strong knowledge safety and entry controls is crucial — and startups should be capable to clearly clarify how they handle these issues earlier than any well being tech investor will take them significantly, he defined.
Shah additionally identified that startups could need to make their enterprise fashions extra versatile.
“One of many issues [investors] have a tendency to consider is how firms can function in very completely different cost fashions — whether or not it’s fee-for-service, value-based or one thing within the center, and likewise how they will prolong throughout a number of elements of the healthcare system,” he said.
As an instance this concept, Shah highlighted Centivo — a startup that raised $75 million in September. The corporate is a well being plan that solely sells to self-funded employers, however it additionally works with suppliers and payers.
“Employers are their prospects. That stated, they completely leverage suppliers, as a result of suppliers assist create their product. They’ve direct contracts with well being methods throughout the nation, and so they additionally work with payers to assist members who will not be the fitting match for Centivo’s community of suppliers. So that they sit in the course of all three of those ecosystems as their prospects make selections,” Shah remarked.
Going ahead, he thinks it is going to turn into increasingly more uncommon for healthcare startups to stay engaged in only one vertical. Sensible founders take note of the broader healthcare market, so they’re conscious of this and might adapt their enterprise fashions as want be, Shah famous.
Regardless of considerably uneven waters over the previous few years, the digital well being sector has remained versatile, he stated.
Buyers’ rising curiosity in supporting AI, value-based care fashions and instruments that deal with administrative bottlenecks present that the sector is aligning itself extra carefully with the wants of suppliers, payers and sufferers. Whereas this transformation has been gradual, Shah thinks it factors to a extra sustainable future for digital well being.
Photograph: abluecup, Getty Pictures